Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Clinical and Experimental Rheumatology|November 4, 2014
The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28)P L C M van RielClinical and Experimental Rheumatology|November 7, 2006
DAS remission cut pointsJ Fransen, P L C M van RielBest Practice & Research. Clinical Rheumatology|March 14, 2007
Management of established rheumatoid arthritis with an emphasis on pharmacotherapyM Blom, P L C M van RielClinical and Experimental Rheumatology|November 9, 2005
The Disease Activity Score and the EULAR response criteriaJ Fransen, P L C M van RielRheumatology (Oxford, England)|July 9, 2004
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteriaJ Fransen, M C W Creemers, P L C M Van RielRheumatology (Oxford, England)|June 20, 2006
Titration of infliximab treatment in rheumatoid arthritis patients based on response patternsM Flendrie, M C W Creemers, P L C M van RielAnnals of the Rheumatic Diseases|April 15, 2005
Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trialJ Fransen, H Bernelot Moens, I Speyer, et al.Clinical Rheumatology|February 11, 2014
Additive value for ultrasonographic signal in a screening algorithm for patients presenting with acute mono-/oligoarthritis in whom gout is suspectedF B G Lamers-Karnebeek, P L C M Van Riel, T L JansenAnnals of the Rheumatic Diseases|August 19, 2003
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritisP Barrera, W J G Oyen, O C Boerman, et al.Rheumatology (Oxford, England)|December 16, 2004
The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational studyM Flendrie, M C W Creemers, P M J Welsing, et al.Pageof 8